Recalls / Firms / Takeda Development Center Americas, Inc.
Takeda Development Center Americas, Inc.
2 FDA drug recalls on record.
| Date | Class | Drug | Status |
|---|---|---|---|
| 2018-11-06 | Class III | Amitiza | Terminated |
| 2018-09-10 | Class II | Actoplus met XR (pioglitazone and metformin HCl, extended-release) tablets, 15 mg/1000 mg, | Terminated |